<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
GLMD
Galmed
$
()


  • Galmed announces grant of European patent

    3/15/2024 - 09:01am
  • Galmed price target lowered to $1 from $4 at Maxim

    11/22/2023 - 08:14am
  • Galmed announces 6 months delay to begin with PSC Ph 2a Study

    11/20/2023 - 16:46pm
  • One new option listing and twelve option delistings on October 30th

    10/30/2023 - 08:30am
  • Galmed granted new patent for aramchol in Japan

    9/26/2023 - 08:35am
  • Galmed upgraded to Buy from Hold at Maxim

    7/24/2023 - 07:21am
  • Galmed files to sell ordinary shares, no amount given

    6/16/2023 - 16:19pm
  • Galmed reports Q1 EPS ($1.09) vs. ($3.67) last year

    6/1/2023 - 08:06am
  • Galmed management to meet with Maxim

    5/16/2023 - 04:55am
  • Galmed management to meet with Maxim

    5/9/2023 - 12:28pm
  • Galmed initiates program to evaluate Primary Sclerosing Cholangitis

    5/9/2023 - 07:27am
  • Biotech Alert: Searches spiking for these stocks today

    5/8/2023 - 11:00am
dynamic_feed Breaking News